574625 Sigma-AldrichSuramin, Sodium Salt - CAS 129-46-4 - Calbiochem
A reversible and competitive inhibitor of protein tyrosine phosphatases.
More>> A reversible and competitive inhibitor of protein tyrosine phosphatases. Less<<Sinonimi: P2Y Antagonist I, Purinergic Receptor P2Y Antagonist I, PTP Inhibitor VI
Prodotti consigliati
Panoramica
| Replacement Information |
|---|
Tabella delle specifiche principali
| CAS # | Empirical Formula |
|---|---|
| 129-46-4 | C₅₁H₃₄N₆O₂₃S₆ . 6Na |
Prezzi e disponibilità
| Numero di catalogo | Disponibilità | Confezionamento | Qtà/conf | Prezzo | Quantità | |
|---|---|---|---|---|---|---|
| 574625-50MG |
|
Fiala di plastica | 50 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 129-46-4 |
| ATP Competitive | N |
| Form | White to beige to peach crystalline solid |
| Hill Formula | C₅₁H₃₄N₆O₂₃S₆ . 6Na |
| Chemical formula | C₅₁H₃₄N₆O₂₃S₆ . 6Na |
| Hygroscopic | Hygroscopic |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | protein tyrosine phosphatases |
| Primary Target IC<sub>50</sub> | 15 µM against phospholipase D |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | QM7000000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Numero di catalogo | GTIN |
| 574625-50MG | 04055977189636 |
Documentation
Suramin, Sodium Salt - CAS 129-46-4 - Calbiochem MSDS
| Titolo |
|---|
Suramin, Sodium Salt - CAS 129-46-4 - Calbiochem Certificati d'Analisi
| Titolo | Numero di lotto |
|---|---|
| 574625 |
Riferimenti bibliografici
| Panoramica delle referenze |
|---|
| Meyers, M.O., et al. 2000. J. Surg. Res. 91, 130. Hohenegger, M., et al. 1998. Proc. Natl. Acad. Sci. USA 95, 346. Waldhoer, M., et al. 1998. Mol. Pharmacol. 53, 808. Zhang, Y.L., et al. 1998. J. Biol. Chem. 273, 12281. Hohenegger, M., et al. 1996. Mol. Pharmacol. 50, 1443. Emmick, J.J., et al. 1994. J. Pharmacol. Exp. Ther. 269, 717. Denhertog, A., et al. 1992. J. Physiol. 454, 591. Nakajima, M., et al. 1991. J. Biol. Chem. 266, 9661. Wilks, J.W., et al. 1991. Int. J. Radiat. Biol. 60, 73. Huang, R.C., et al. 1990. Mol. Pharmacol. 37, 304. Kopp, R. and Pfeiffer, A. 1990. Cancer Res. 50, 6490. |
Scheda tecnica
| Titolo |
|---|
| SIRTainty™ Class III HDAC Assay |



